Aptar appoints Sarah Glickman to its Board of Directors
Sarah currently serves as the Chief Financial Officer and Principal Accounting Officer for Criteo S.A.
Sarah currently serves as the Chief Financial Officer and Principal Accounting Officer for Criteo S.A.
Planned investment of approximately USD 90 million to build a state-of-the-art Sandoz Biosimilar Technical Development Center in Ljubljana, Slovenia by 2026
The product will be produced at the Eugia Pharma Specialities, Unit-I, Medchal, Malkajgiri District, Telangana, India
The drug exhibited greater treatment persistence and control of moderate-to-severe PsO symptoms compared to secukinumab and ixekizumab
Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01 January 2026.
Several late-stage pipeline products have the potential to address some of these unmet needs
The Congress gathers the whole value chain of the pharmaceutical industry on June, 12-13, 2023 in Switzerland
She is a seasoned leader with nearly 30 years of business leadership and consulting experience with top companies such as Mckinsey and Co, Novartis Pharmaceuticals and Stryker India Pvt. Ltd.
Her previous role at Novartis, where she was general manager, data & digital, in global drug development, also included accountability for driving the DCT strategy, programs and platforms
Move to increase affordability and accessibility for heart failure patients across the country
Subscribe To Our Newsletter & Stay Updated